Hazem Shahin, MD
Advertisement
Dr Shahin is assistant professor at Baylor College of Medicine, certified in general psychiatry & addiction psychiatry, and specializing clinically in the area of complex psychopharmacology management in the setting of cooccurring mental and physical disorders.
Articles by Hazem Shahin, MD
Due to ethical, knowledge, cost, and acceptability issues, deep brain stimulation is underutilized in disease states like treatment-resistant schizophrenia.
Advertisement
Latest Updated Articles
DBS: A Solution to Treatment-Resistant SchizophreniaPublished: May 14th 2024 | Updated:
Treatment-Resistant Schizophrenia: Can DBS Be the Solution?Published: October 23rd 2023 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Approves ProlivRX: First Prescription, Physician-Directed, At-Home Brain Neuromodulation Therapy for MDD
2
What Makes It So Special? A Review of the Mechanisms of Action of Lamotrigine, Carbamazepine, and Valproic Acid and How They Differ From Other Antiepileptics
3
Anticholinergic Burden and Its Effect on Cognition in Psychosis
4
Progress Report: Second Interim Safety Review of Phase 3 Trial of LPCN 1154 in Postpartum Depression
5